This is an external website. DAIC is not responsible for any content on the third party website.
Aug. 4, 2026 — Abbott has completed enrollment in its TECTONIC coronary artery disease (CAD) Intravascular Lithotripsy ...
July 7, 2026 —AtaCor Medical has announced the enrollment of the first patient in the company's ALARION-EV trial ...
April 14, 2026 — Implicity, a provider of remote patient monitoring and cardiac data management solutions, recently ...
Feb. 27, 2026 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s CardioMEMS Hero device — a pulmonary ...
March 27, 2025 — Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients ...
March 25, 2024 — Abbott announced the first patient has been enrolled in the ENVISION investigational device exemption ...
February 15, 2024 — Abbott announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee ...
July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to ...
July 19, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...
July 5, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR dual chamber (DR ...